title: Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
abstract: Oncogenic Kras initiates pancreatic tumorigenesis, while subsequent genetic events shape the resultant disease. We show here that concomitant expression of Kras(G12D) and haploinsufficiency of the Smad4/Dpc4 tumor suppressor gene engenders a distinct class of pancreatic tumors, mucinous cystic neoplasms (MCNs), which culminate in invasive ductal adenocarcinomas. Disease evolves along a progression scheme analogous to, but distinct from, the classical PanIN-to-ductal adenocarcinoma sequence, and also portends a markedly different prognosis. Progression of MCNs is accompanied by LOH of Dpc4 and mutation of either p53 or p16. Thus, these distinct phenotypic routes to invasive adenocarcinoma nevertheless share the same overall mutational spectra. Our findings suggest that the sequence, as well as the context, in which these critical mutations are acquired helps determine the ensuing pathology.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
authors.forename: Kamel
authors.initials: K
authors.lastname: Izeradjene
authors.forename: Chelsea
authors.initials: C
authors.lastname: Combs
authors.forename: Melissa
authors.initials: M
authors.lastname: Best
authors.forename: Aarthi
authors.initials: A
authors.lastname: Gopinathan
authors.forename: Amary
authors.initials: A
authors.lastname: Wagner
authors.forename: William M
authors.initials: WM
authors.lastname: Grady
authors.forename: Chu-Xia
authors.initials: CX
authors.lastname: Deng
authors.forename: Ralph H
authors.initials: RH
authors.lastname: Hruban
authors.forename: N Volkan
authors.initials: NV
authors.lastname: Adsay
authors.forename: David A
authors.initials: DA
authors.lastname: Tuveson
authors.forename: Sunil R
authors.initials: SR
authors.lastname: Hingorani
mesh_terms: D000818:Animals; D021441:Carcinoma, Pancreatic Ductal / Q000235:genetics* / Q000473:pathology; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism; D018291:Cystadenoma, Mucinous / Q000235:genetics* / Q000473:pathology; D004195:Disease Models, Animal; D011905:Genes, ras; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D051379:Mice; D008817:Mice, Mutant Strains; D009154:Mutation; D009361:Neoplasm Invasiveness; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D011379:Prognosis; D015398:Signal Transduction; D051901:Smad4 Protein / Q000235:genetics / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D051901:Smad4 Protein; C490810:Smad4 protein, mouse; D016212:Transforming Growth Factor beta; D016159:Tumor Suppressor Protein p53